Alisertib (MLN8237)

For research use only.

Catalog No.S1133

268 publications

Alisertib (MLN8237) Chemical Structure

CAS No. 1028486-01-2

Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a cell-free assay. It has >200-fold higher selectivity for Aurora A than Aurora B. Alisertib induces cell cycle arrest, apoptosis and autophagy. Phase 3.

Selleck's Alisertib (MLN8237) has been cited by 268 publications

Purity & Quality Control

Choose Selective Aurora Kinase Inhibitors

Biological Activity

Description Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a cell-free assay. It has >200-fold higher selectivity for Aurora A than Aurora B. Alisertib induces cell cycle arrest, apoptosis and autophagy. Phase 3.
Features First orally available inhibitor of Aurora A.
Targets
Aurora A [1]
(Cell-free assay)
1.2 nM
In vitro

MLN8237 shows >200-fold higher selectivity for Aurora A than the structurally related Aurora B with an IC50 of 396.5 nM, and does not have any significant activity against 205 other kinases. [1] MLN8237 (0.5 μM) treatment inhibits the phosphorylation of Aurora A in MM1.S and OPM1 cells, without affecting the Aurora B mediated histone H3 phosphorylation. MLN8237 significantly inhibits cell proliferation in multiple myeloma (MM) cell lines with IC50 values of 0.003-1.71 μM. MLN8237 displays more potent anti-proliferation activity against primary MM cells and MM cell lines in the presence of BM stroma cells, as well as IL-6 and IGF-1 than against MM cells alone. MLN8237 (0.5 μM) induces 2- to 6-fold increase in G2/M phase in primary MM cells and cell lines, as well as significant apoptosis and senescence, involving the up-regulation of p53, p21 and p27, as well as PARP, caspase 3, and caspase 9 cleavage. In addition, MLN8237 shows strong synergistic anti-MM effect with dexamethasone, as well as additive effect with doxorubicin and bortezomib. [2] MLN8237 (0.5 μM) treatment causes the inhibition of colony formation of FLO-1, OE19, and OE33 esophageal adenocarinoma cell lines, and induces a significant increase in the percentage of polyploid cells, and subsequently an increase in the percentage of cells in the sub-G1 phase, which can be further enhanced in combination with cisplatin (2.5 μM), involving the higher induction of TAp73β, PUMA, NOXA, cleaved caspase-3, and cleaved PARP as compared with a single-agent treatment. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HCT116 MkTTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVPaNXN1OC53IN88US=> M{fJPFczKGh? NUDCVZpQTE2VTx?= M{XKVmlEPTB;MD6wOEDPxE1? NVLlNFJ{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[xN|Y3QDRpPkK2NVM3Pjh2PD;hQi=>
LS174T MnHZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXXtcXZDOC53IN88US=> M2\zeVczKGh? Mn3rSG1UVw>? NY\zPWw4UUN3ME2wMlA2KM7:TR?= MmeyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzM{[2PFQoRjJ4MUO2Olg1RC:jPh?=
T84 NFrzNWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NE\xNYUxNjVizszN MY[3NkBp MYjEUXNQ M3HIXmlEPTB;MD6wPUDPxE1? MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjF|Nk[4OEc,OjZzM{[2PFQ9N2F-
LS180 M2jiS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\xV2pEOC53IN88US=> NGP3SZk4OiCq NWDo[lFJTE2VTx?= NYfCb3FyUUN3ME2xJO69VQ>? Mn:wQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzM{[2PFQoRjJ4MUO2Olg1RC:jPh?=
SW948 NXXad5UzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXewMlUh|ryP Mn7YO|IhcA>? M{XMZ2ROW09? M{TwXWlEPTB;MTFOwG0> M3nOelxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MUO2Olg1Lz5{NkGzOlY5PDxxYU6=
HCT15 NGTx[2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEXNR4MxNjVizszN MmK4O|IhcA>? M{[0S2ROW09? MnqzTWM2ODxyLkSg{txO NFPRU|Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkGzOlY5PCd-Mk[xN|Y3QDR:L3G+
DLD-1 MkPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3fETFAvPSEQvF2= MVG3NkBp MmLzSG1UVw>? M3rRdGlEPTB:MD64JO69VQ>? NHuxPXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkGzOlY5PCd-Mk[xN|Y3QDR:L3G+
MIP-101 NVfmW5JsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHYc4QxNjVizszN MVy3NkBp M3\BNWROW09? M{nZO2lEPTB;MTFOwG0> NIPuNG09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkGzOlY5PCd-Mk[xN|Y3QDR:L3G+
SNU1544 Mn\nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGLCO2sxNjVizszN MWK3NkBp NXn3ZpptTE2VTx?= NH3yZohKSzVyPUGg{txO NYqweFBXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[xN|Y3QDRpPkK2NVM3Pjh2PD;hQi=>
OCI-Ly10 NYDXT3A2S3m2b4TvfIlkKEG|c3H5 NFX4fJQ4OiCq MYLEUXNQ M3jVcWlEPTB;MD6wOVgh|ryP M{\JN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEe4N|MyLz5{NUi3PFM{OTxxYU6=
SU-DHL2 NIfJdolEgXSxdH;4bYMhSXO|YYm= NFzVe2Q4OiCq MVfEUXNQ M2L6XGlEPTB;MD6wNUDPxE1? MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
OCI-LY7 MXnDfZRwfG:6aXOgRZN{[Xl? NEOyNmU4OiCq NIDl[nhFVVOR MlPmTWM2OD1yLkC4NUDPxE1? MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
SU-DHL6 MXvDfZRwfG:6aXOgRZN{[Xl? M2qxRVczKGh? M33nN2ROW09? NG\PdVlKSzVyPUCuOFgzKM7:TR?= NUD2ZlhTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
Jeko-1 M3jVWWN6fG:2b4jpZ{BCe3OjeR?= NVzYelRUPzJiaB?= M3;DbWROW09? NEHuNlZKSzVyPUCuNFI6KM7:TR?= MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
JVM-2 NGXqVIxEgXSxdH;4bYMhSXO|YYm= NF\pepE4OiCq MYfEUXNQ MoW1TWM2OD1yLkCxJO69VQ>? M2DEOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEe4N|MyLz5{NUi3PFM{OTxxYU6=
Rec-1 NFP6eVlEgXSxdH;4bYMhSXO|YYm= NXvsW285PzJiaB?= NXXLUoE3TE2VTx?= NVLkcJZTUUN3ME2wMlA5PyEQvF2= MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
Z-138 NGrMPIZEgXSxdH;4bYMhSXO|YYm= M1HyVVczKGh? NUPZfFJDTE2VTx?= M3\GZmlEPTB;MD6wNVMh|ryP MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
H9 MnS0R5l1d3SxeHnjJGF{e2G7 NXzTXW1oPzJiaB?= NFrkbGxFVVOR MVPJR|UxRTBwNjFOwG0> NV;oPWJLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
HH M3\L[GN6fG:2b4jpZ{BCe3OjeR?= M3XqPFczKGh? MoixSG1UVw>? NXXVWVdYUUN3ME2wMlch|ryP NWq1Z2VjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
DND41 MWfDfZRwfG:6aXOgRZN{[Xl? NEnXcpI4OiCq MWjEUXNQ NGPyOZdKSzVyPUCuNUDPxE1? MknSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6N{izN|EoRjJ3OEe4N|MyRC:jPh?=
CCL119 MlXJR5l1d3SxeHnjJGF{e2G7 MWW3NkBp MojsSG1UVw>? NVf3[JZ5UUN3ME2wMlA3OiEQvF2= NU\iU|B7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
J.Cam 1.6 M3zSNmN6fG:2b4jpZ{BCe3OjeR?= NEDLT4M4OiCq MnyxSG1UVw>? NUPqV25uUUN3ME2wMlExPSEQvF2= MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
Sup-T1 MnLXR5l1d3SxeHnjJGF{e2G7 NH:4eow4OiCq Mk\VSG1UVw>? M4G2dGlEPTB;Mj6xOFIh|ryP MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
Tib 152 MoD5R5l1d3SxeHnjJGF{e2G7 NGjiXYE4OiCq MnjTSG1UVw>? MmTTTWM2OD1yLkig{txO M4TpdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEe4N|MyLz5{NUi3PFM{OTxxYU6=
MCF7 NWjKSItuTnWwY4Tpc44hSXO|YYm= MX:1JO69VQ>? MmiwNlQhcA>? M4\U[GROW09? MV7JcoR2[2W|IFeyM20h[XK{ZYP0 MknnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MDA-MB-231 M4\LWWZ2dmO2aX;uJGF{e2G7 MYG1JO69VQ>? MYqyOEBp NXPLdGhFTE2VTx?= MlPJTY5lfWOnczDHN{9OKGG{cnXzeC=> MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
MCF7 NHrlTGFHfW6ldHnvckBCe3OjeR?= M3\xOFUh|ryP MorCNlQhcA>? M{jQfmROW09? M2PsbGRm[3KnYYPld{B1cGViZYjwdoV{e2mxbjDs[ZZmdCCxZjDDSGsyN0OGQ{K= MoDIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MCF7 NEXNUlhHfW6ldHnvckBCe3OjeR?= MXK1JO69VQ>? NUS4XG5COjRiaB?= M33CSmROW09? NUHWbWY2TGWlcnXhd4V{KHSqZTDlfJBz\XO|aX;uJIxmfmWuIH;mJGNFUzJ? MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
MCF7 Mlf1SpVv[3Srb36gRZN{[Xl? MlPQOUDPxE1? MUWyOEBp NHrVOWxFVVOR NFztbFdF\WO{ZXHz[ZMhfGinIHX4dJJme3Orb36gcIV3\Wxib3[gZ5lkdGmwIFKx NGTsO5I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUizOFQxOSd-MkW4N|Q1ODF:L3G+
MCF7 Mmn6SpVv[3Srb36gRZN{[Xl? Mlu3OUDPxE1? Mkf3NlQhcA>? MV\EUXNQ MV;JcoNz\WG|ZYOgeIhmKGW6cILld5Nqd25ibHX2[Ywhd2ZicEKxJHdi\jFxQ3nwNS=> M13HdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEO0OFAyLz5{NUizOFQxOTxxYU6=
MCF7 M17qPWZ2dmO2aX;uJGF{e2G7 NH[0TWo2KM7:TR?= M3nRTVI1KGh? NVTBWW5LTE2VTx?= MXLJcoNz\WG|ZYOgeIhmKGW6cILld5Nqd25ibHX2[Ywhd2ZicEK3JGtqeDF? M3\Ye|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEO0OFAyLz5{NUizOFQxOTxxYU6=
MDA-MB-231 NIL0O3lHfW6ldHnvckBCe3OjeR?= NGLEUlI2KM7:TR?= M1nBRlI1KGh? M2HrSWROW09? NFPxfpJF\WO{ZXHz[ZMhfGinIHX4dJJme3Orb36gcIV3\Wxib3[gR2RMOS:FRFOy MnzCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MDA-MB-231 NXTINldjTnWwY4Tpc44hSXO|YYm= MkWzNUDPxE1? NFyyZ2UzPCCq NGrEUZFFVVOR MoXKTY5kemWjc3XzJJRp\SCneIDy[ZN{cW:wIHzleoVtKG:oIFPET|I> NWe4U5N2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4N|Q1ODFpPkK1PFM1PDBzPD;hQi=>
MDA-MB-231 MlXWSpVv[3Srb36gRZN{[Xl? MX:1JO69VQ>? MnH5NlQhcA>? Mn7aSG1UVw>? MWnE[YNz\WG|ZYOgeIhmKGW6cILld5Nqd25ibHX2[Ywhd2ZiY4njcIlvKEJz M3jvfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEO0OFAyLz5{NUizOFQxOTxxYU6=
MDA-MB-231 NFrUfWpHfW6ldHnvckBCe3OjeR?= MW[1JO69VQ>? MkXNNlQhcA>? MX3EUXNQ NVnubpRQUW6lcnXhd4V{KHSqZTDlfJBz\XO|aX;uJIxmfmWuIH;mJJAzOSCZYX[xM2NqeDF? NXvqdFQ4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4N|Q1ODFpPkK1PFM1PDBzPD;hQi=>
MDA-MB-231 M{XZS2Z2dmO2aX;uJGF{e2G7 MmPIOUDPxE1? M4TwfFI1KGh? NVrkVZh2TE2VTx?= MYjJcoNz\WG|ZYOgeIhmKGW6cILld5Nqd25ibHX2[Ywhd2ZicEK3JGtqeDF? MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
MDA-MB-231 NEDKSFlHfW6ldHnvckBCe3OjeR?= NU\6Tm1SPSEQvF2= NVO0W2F[OjRiaB?= NHy4[GNFVVOR M3znWGlv[3KnYYPld{B1cGViZYjwdoV{e2mxbjDs[ZZmdCCxZjDwOVM> NF3vWWk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUizOFQxOSd-MkW4N|Q1ODF:L3G+
MCF7 NVHnXI9YSXCxcITvd4l{KEG|c3H5 M1nxcVUh|ryP NEHKXmczPCCq M3HoVGROW09? MX\JcoR2[2W|IHHwc5B1d3SrYzDk[YF1cA>? MlP4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MDA-MB-231 M{XjWGFxd3C2b4Ppd{BCe3OjeR?= M2DMRlUh|ryP MVuyOEBp NWTaN5NrTE2VTx?= NGPKNHBKdmS3Y3XzJIFxd3C2b4TpZ{Bl\WG2aB?= MlT5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MCF7 NH3NXmxHfW6ldHnvckBCe3OjeR?= MmS2NUDPxE1? MUS3NkBp M3nkbmROW09? MmnNTY5lfWOnczDheZRweGijZ3njJIRm[XSq MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
MDA-MB-231 MmrISpVv[3Srb36gRZN{[Xl? NYjJUZNkOSEQvF2= MVe3NkBp MmjJSG1UVw>? NUXxNmhtUW6mdXPld{BifXSxcHjh[4lkKGSnYYTo MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
U-2 OS NI[wUlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlXlOVAh|ryP MnXNNlQhcA>? NYD0OWxzTE2VTx?= MnTSTWM2OD1zNj62JO69VQ>? NHfHTYs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUe5NlgyOSd-MkW3PVI5OTF:L3G+
MG-63 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWDaO3ZYPTBizszN NG\EUmUzPCCq Ml\DSG1UVw>? M3HQRmlEPTB;OT61JO69VQ>? NXqzellZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3PVI5OTFpPkK1O|kzQDFzPD;hQi=>
U-2 OS MWHBdI9xfG:|aYOgRZN{[Xl? Mn;2OUDPxE1? Ml\nNlQhcA>? NEPDe|VFVVOR NFPoXohKdmS3Y3XzJIFxd3C2b4TpZ{Bk\WyuIHTlZZRp NUXUV5NsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3PVI5OTFpPkK1O|kzQDFzPD;hQi=>
MG-63 M4nFTmFxd3C2b4Ppd{BCe3OjeR?= M4nEflUh|ryP NG\JbpYzPCCq NYLKdI9oTE2VTx?= NVS2c|R2UW6mdXPld{BieG:ydH;0bYMh[2WubDDk[YF1cA>? NXLuS25bRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3PVI5OTFpPkK1O|kzQDFzPD;hQi=>
U-2 OS M{G5[GZ2dmO2aX;uJGF{e2G7 NUXCcmg6PSEQvF2= MYqyOEBp M3r3TmROW09? M1G4N3Bzd22xdHXzJIF2fG:yaHHnbYMh[2WubDDk[YF1cA>? M4LublxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{myPFEyLz5{NUe5NlgyOTxxYU6=
MG-63 Mn7KSpVv[3Srb36gRZN{[Xl? M{jsXVUh|ryP M2PPVVI1KGh? NWT4e3ZmTE2VTx?= MWLQdo9ud3SnczDheZRweGijZ3njJINmdGxiZHXheIg> NG\UN4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUe5NlgyOSd-MkW3PVI5OTF:L3G+
PANC-1 Ml7nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYC1NEDPxE1? MmXPNlQhcA>? NHnHT2pFVVOR M1jTNWlEPTB;Nz6xJO69VQ>? NFnET2M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[zNlIzPSd-MkW2N|IzOjV:L3G+
BxPC-3 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWe1NEDPxE1? MWSyOEBp M4TJfWROW09? MW\JR|UxRTZwODFOwG0> NF\LPHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[zNlIzPSd-MkW2N|IzOjV:L3G+
PANC-1 NIf2VG1HfW6ldHnvckBCe3OjeR?= NF\sNnc2KM7:TR?= NH;RXJozPCCq MnP0SG1UVw>? NXzsZZBkUW6mdXPld{Bk\WyuIHP5Z4xmKGG{cnXzeEBqdiCJMj;NJJBp[XOn M2HHT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkOyNlI2Lz5{NU[zNlIzPTxxYU6=
BxPC-3 NV;VWI0{TnWwY4Tpc44hSXO|YYm= M3\PSlUh|ryP M1jwUlI1KGh? NGrhelFFVVOR MWnJcoR2[2W|IHPlcIwh[3mlbHWgZZJz\XO2IHnuJGczN01icHjhd4U> Mnj5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4M{KyNlUoRjJ3NkOyNlI2RC:jPh?=
PANC-1 M33PSWZ2dmO2aX;uJGF{e2G7 Mn:1OUDPxE1? MmPJNlQhcA>? M2D6ZWROW09? MmHzTY5lfWOnczDheZRweGijZ3njJINmdGxiZHXheIg> NX;yZ|NGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2N|IzOjVpPkK1OlMzOjJ3PD;hQi=>
BxPC-3 NUS2dnFFTnWwY4Tpc44hSXO|YYm= MoXOOUDPxE1? MmHRNlQhcA>? MlPoSG1UVw>? MXfJcoR2[2W|IHH1eI9xcGGpaXOgZ4VtdCCmZXH0bC=> M4DtdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkOyNlI2Lz5{NU[zNlIzPTxxYU6=
SKOV3 NWLwdWRUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn\oNVAxKM7:TR?= MVGyOEBp MoPJSG1UVw>? M1HaeGlEPTB;MkCuOFgh|ryP MmDaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkS3OVAoRjJ3NkK0O|UxRC:jPh?=
OVCAR4 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVrtRXkxOTByIN88US=> NHqyZXEzPCCq MnntSG1UVw>? M1jnS2lEPTB;MkKuNVMh|ryP MonhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkS3OVAoRjJ3NkK0O|UxRC:jPh?=
SKOV3 MWDGeY5kfGmxbjDBd5NigQ>? MYG1JO69VQ>? NI\wRYU4OiCq NE[wWXNFVVOR NVfuUY14UW6mdXPld{BIOi:PIHHydoV{fA>? MkjoQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkS3OVAoRjJ3NkK0O|UxRC:jPh?=
OVCAR4 M{\EVGZ2dmO2aX;uJGF{e2G7 NETkTWY2KM7:TR?= MVi3NkBp NHXKSYVFVVOR M3nDSWlv\HWlZYOgS|IwVSCjcoLld5Q> NYq5[mRCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlQ4PTBpPkK1OlI1PzVyPD;hQi=>
SKOV3 MkfjRZBweHSxc3nzJGF{e2G7 NGPXdlM2KM7:TR?= NV;KOXo4OjRiaB?= M{PjfGROW09? M13sTWlv\HWlZYOgZZBweHSxc3nz MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NEe1NEc,OjV4MkS3OVA9N2F-
OVCAR4 MmPoRZBweHSxc3nzJGF{e2G7 Mmi0OUDPxE1? NFztO5kzPCCq MkTiSG1UVw>? M2HTfWlv\HWlZYOgZZBweHSxc3nz MnzZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkS3OVAoRjJ3NkK0O|UxRC:jPh?=
AGS Mn;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlzvNlUh|ryP NFHTZ4UzPCCq M1y5V2ROW09? MXXJR|UxRTF7LkC5JO69VQ>? NX30dGx[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NFk6OjNpPkK1OlA6QTJ|PD;hQi=>
NCI-N78 Ml3KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3zrUlI2KM7:TR?= M4HtU|I1KGh? MnvjSG1UVw>? NUfpd3lGUUN3ME2yOk4{OyEQvF2= MnPjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MEm5NlMoRjJ3NkC5PVI{RC:jPh?=
AGS MXXBdI9xfG:|aYOgRZN{[Xl? M3mx[|Uh|ryP NVv6SG5SOjRiaB?= M{nmZWROW09? NVXr[Ip6UW6mdXPld{BieG:ydH;zbZM> M4nyZ|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkC5PVI{Lz5{NU[wPVkzOzxxYU6=
NCI-N78 MlPYRZBweHSxc3nzJGF{e2G7 M1X4dFUh|ryP M2\HTFI1KGh? NYXmN4ViTE2VTx?= NEPldW5KdmS3Y3XzJIFxd3C2b4Ppdy=> M1nlTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkC5PVI{Lz5{NU[wPVkzOzxxYU6=
AGS M3uzXWZ2dmO2aX;uJGF{e2G7 MnzrOUDPxE1? MnK4NlQhcA>? MYrEUXNQ M12zc2lv\HWlZYOgeIhmKGG3dH;wbIFogQ>? NY\PVms6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NFk6OjNpPkK1OlA6QTJ|PD;hQi=>
NCI-N78 NYnyN4JQTnWwY4Tpc44hSXO|YYm= M2jCUlUh|ryP NHf6e3QzPCCq NVL5bWg3TE2VTx?= NUGwXohEUW6mdXPld{B1cGViYYX0c5Bp[We7 NUXze45ORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NFk6OjNpPkK1OlA6QTJ|PD;hQi=>
HSC-3 M3HCOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYexJO69VQ>? NYC5XnRiPDhiaB?= MkD0TWM2OD1yLkW0JO69VQ>? NE\QRmw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUO2OlE1Oyd-MkWzOlYyPDN:L3G+
GB30 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn:5NUDPxE1? MXS3JIQ> MWrEUXNQ M{HmfmlEPTB;MD6wNVEh|ryP MlLaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzME[0NlgoRjJ3MUC2OFI5RC:jPh?=
GB9 NHfpcGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3jFe|Eh|ryP M4j3c|ch\A>? NXrJTohJTE2VTx?= M3TRT2lEPTB;MD6wNlQh|ryP NXzTVXBRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxNFY1OjhpPkK1NVA3PDJ6PD;hQi=>
GB169 NGfFdHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVyxJO69VQ>? M361elch\A>? M3vhbmROW09? MnTrTWM2OD1yLkCzNkDPxE1? NE\URpE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUGwOlQzQCd-MkWxNFY1Ojh:L3G+
T24 M163bWZ2dmO2aX;uJGF{e2G7 MV2xJO69VQ>? MkfaOFghcA>? MWrEUXNQ M33PUGlv\HWlZYOgZ4VtdCCleXPs[UBienKnc4S= NF32dmE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SwN|Y{Oyd-MkO0NFM3OzN:L3G+
RT4 M3niTmZ2dmO2aX;uJGF{e2G7 NE[xNXAyKM7:TR?= MoPNOFghcA>? MkLiSG1UVw>? NXjpS|JMUW6mdXPld{Bk\WyuIHP5Z4xmKGG{cnXzeC=> NIrN[2Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SwN|Y{Oyd-MkO0NFM3OzN:L3G+
UM-UC-3 NEThdGxHfW6ldHnvckBCe3OjeR?= M4CwXlEh|ryP MXm0PEBp NESwWYxFVVOR MoO5TY5lfWOnczDj[YxtKGO7Y3zlJIFzemW|dB?= MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRyM{[zN{c,OjN2MEO2N|M9N2F-
T24 NVqxZ4FISXCxcITvd4l{KEG|c3H5 NEjsWY4{NjF4IN88US=> MX25OkBp MUfEUXNQ MYnJR|UxRTBwMEOwOkDPxE1? MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRyM{[zN{c,OjN2MEO2N|M9N2F-
RT4 M3P1RmFxd3C2b4Ppd{BCe3OjeR?= NWLFVXdMOy5zNjFOwG0> MV65OkBp M33BbGROW09? NYXjfXNbUUN3ME2wMlEyQThizszN MoXSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MEO2N|MoRjJ|NECzOlM{RC:jPh?=
UM-UC-3 NVHCT2F[SXCxcITvd4l{KEG|c3H5 M1;B[|MvOTZizszN M1\yTFk3KGh? NWSwd|N1TE2VTx?= M3nQ[GlEPTB;MD6wOFQ6KM7:TR?= MmrLQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MEO2N|MoRjJ|NECzOlM{RC:jPh?=
OVCAR-5 Ml\tSpVv[3Srb36gRZN{[Xl? NFTjRoQ2OCCwTR?= NEnq[VlKdmirYnn0d{Bk\WyuIH3p[5JifGmxbh?= MlyxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|M{SzNlcoRjJ|M{O0N|I4RC:jPh?=
SKOV3ip2 MUTGeY5kfGmxbjDBd5NigQ>? M3;wdlUxKG6P NVLBPYo2UW6qaXLpeJMh[2WubDDtbYdz[XSrb36= M1[xeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{O0N|I4Lz5{M{OzOFMzPzxxYU6=
S462 MlPES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoX5NVAxKM7:TR?= MVu3NkBp NX\QVHJvTE2VTx?= NHzaPG5CfHSnboXheIV{KGOnbHyg[5Jwf3Sq MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzN{OEGxOEc,OjN|MkixNVQ9N2F-
2884 NWDWT|g6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XTOVExOCEQvF2= MmnHO|IhcA>? M1\nR2ROW09? M3zwVGF1fGWwdXH0[ZMh[2WubDDndo94fGh? MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzN{OEGxOEc,OjN|MkixNVQ9N2F-
2885 NGDIOm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M37GWFExOCEQvF2= NG\vSpE4OiCq MUTEUXNQ MlT4RZR1\W63YYTld{Bk\WyuIHfyc5d1cA>? M4H1Z|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{K4NVE1Lz5{M{OyPFEyPDxxYU6=
CRL-2396 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M364O|ExOCEQvF2= NFvXdoN4[XSnch?= NVzOb|JwUUN3ME2wMlA6OiEQvF2= NWTIdppqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxOVM2OjRpPkKzNVU{PTJ2PD;hQi=>
TIB-48 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVTqXpdkOTByIN88US=> MY\3ZZRmeg>? M2jrc2lEPTB;MD6wPFgh|ryP MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF3M{WyOEc,OjNzNUO1NlQ9N2F-
CRL-2396 MUDDfZRwfG:6aXOgRZN{[Xl? NWjKOHFiOSEQvF2= NEPwVGM1QCCq NYf1OlVVf2G2ZYK= NGXxb4JKdmS3Y3XzJIFxd3C2b4Ppdy=> M{LiTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MUWzOVI1Lz5{M{G1N|UzPDxxYU6=
TIB-48 MXjDfZRwfG:6aXOgRZN{[Xl? NFvx[WcyKM7:TR?= Mo\jOFghcA>? MXT3ZZRmeg>? NVn6PGRTUW6mdXPld{BieG:ydH;zbZM> MlT6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNzNUO1NlQoRjJ|MUWzOVI1RC:jPh?=
AGS MnznR5l1d3SxeHnjJGF{e2G7 MnT4NE42KM7:TR?= NWCyV5MyOjRiaB?= NEPIdWZFVVOR MnzISIVkemWjc3XzJINmdGxic4Xyeol3[Wx? NF7nSmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mkm3NlYyOSd-MkK5O|I3OTF:L3G+
FLO-1 MYTDfZRwfG:6aXOgRZN{[Xl? NXPTXlM2OC53IN88US=> NGnzPHEzPCCq M2TvfGROW09? NHnpemFF\WO{ZXHz[ZMh[2WubDDzeZJ3cX[jbB?= MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl5Mk[xNUc,OjJ7N{K2NVE9N2F-
OE33 NEHGVnVEgXSxdH;4bYMhSXO|YYm= MWqwMlUh|ryP MmLMNlQhcA>? NGf1SJZFVVOR Ml;mSIVkemWjc3XzJINmdGxic4Xyeol3[Wx? MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl5Mk[xNUc,OjJ7N{K2NVE9N2F-
SKLMS MXfDfZRwfG:6aXOgRZN{[Xl? NYjkUXhqPzVibl2= MWS5OkBp MoqzTY5lfWOnczDhdI9xfG:|aYO= M3P4SFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEKxPVk4Lz5{MkiyNVk6PzxxYU6=
Leio285 Ml\oR5l1d3SxeHnjJGF{e2G7 Mlv5O|Uhdk1? M1OxVFk3KGh? MoDlTY5lfWOnczDhdI9xfG:|aYO= MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{MUm5O{c,OjJ6MkG5PVc9N2F-
Mes-Sa MmDWR5l1d3SxeHnjJGF{e2G7 MoXRO|Uhdk1? M1WyVFk3KGh? NYLZNnRjUW6mdXPld{BieG:ydH;zbZM> MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh{MUm5O{c,OjJ6MkG5PVc9N2F-
DAOY MU\DfZRwfG:6aXOgRZN{[Xl? Mo\yNVAh|ryP NX;N[GZmPzJiaB?= NYHxdYcxTE2VTx?= MkfBTWM2OD1yLkC0JO69VQ>? NHrWVJY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mk[2PVM{PSd-MkK2Olk{OzV:L3G+
IMR32 NVzBWoV4S3m2b4TvfIlkKEG|c3H5 NVz0fmpkOTBizszN NILXUWo4OiCq NHq2UYdFVVOR MX7JR|UxRTBwMEOg{txO NFfndWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mk[2PVM{PSd-MkK2Olk{OzV:L3G+
Molt-4 NEP1T41EgXSxdH;4bYMhSXO|YYm= MkLUNVAh|ryP NYHMVHd2PzJiaB?= MWDEUXNQ MoTuTWM2OD1yLkCyJO69VQ>? M3PQOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{Nk[5N|M2Lz5{Mk[2PVM{PTxxYU6=
MOLM-13 NVLnRWpDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3L6bVMh|ryP NHTUUpY4OiCq MXrEbY1qdmm|aHXzJINmdGxidnnhZoltcXS7 NFe3epI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkS4PFI1QSd-MkK0PFgzPDl:L3G+
HL-60 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1;JTFMh|ryP Ml7hO|IhcA>? MYrEbY1qdmm|aHXzJINmdGxidnnhZoltcXS7 M2HmbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NEi4NlQ6Lz5{MkS4PFI1QTxxYU6=
MV4-11 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3KyR|Mh|ryP M4j3WVczKGh? NF\tWXJFcW2rbnnzbIV{KGOnbHygeoli[mmuaYT5 Mn\QQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ2OEiyOFkoRjJ{NEi4NlQ6RC:jPh?=
SKM-1 M{myZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2T4TVMh|ryP NVPsZotmPzJiaB?= NEOyUWhFcW2rbnnzbIV{KGOnbHygeoli[mmuaYT5 NGnBdlM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkS4PFI1QSd-MkK0PFgzPDl:L3G+
SH2 MoK2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M33UN|Mh|ryP NVj5U3RRPzJiaB?= NUiyNHU5TGmvaX7pd4hmeyClZXzsJJZq[WKrbHn0fS=> NUC0UVFORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0PFgzPDlpPkKyOFg5OjR7PD;hQi=>
NOMO-1 MmjGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\BboFROyEQvF2= MoHXO|IhcA>? MWfEbY1qdmm|aHXzJINmdGxidnnhZoltcXS7 NXzmdXQ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0PFgzPDlpPkKyOFg5OjR7PD;hQi=>
OCL-AML2 NHrtd4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYnWbFZqOyEQvF2= NGDBb4g4OiCq NF;oWVRFcW2rbnnzbIV{KGOnbHygeoli[mmuaYT5 NYWzS3Q3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0PFgzPDlpPkKyOFg5OjR7PD;hQi=>
PL-21 MlvVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWDsWHBoOyEQvF2= MojXO|IhcA>? M3PhV2RqdWmwaYPo[ZMh[2WubDD2bYFjcWyrdIm= NF3zcWM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkS4PFI1QSd-MkK0PFgzPDl:L3G+
KG-1 NFXvW2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUG5[483OyEQvF2= MYm3NkBp NETpNW5FcW2rbnnzbIV{KGOnbHygeoli[mmuaYT5 NHrLVmg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkS4PFI1QSd-MkK0PFgzPDl:L3G+
A172 NUDO[FR7S3m2b4TvfIlkKEG|c3H5 NVLXU2hOOTByIN88US=> MlnmNlQhcA>? MnnXSG1UVw>? NYnHNVdlUUN3ME2wMlEzOCEQvF2= M3W5[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{Mke0N|k6Lz5{MkK3OFM6QTxxYU6=
U87 NEWzNoJEgXSxdH;4bYMhSXO|YYm= M3Wy[lExOCEQvF2= MmLHNlQhcA>? MnrwSG1UVw>? MVXJR|UxRTBwMUC1JO69VQ>? MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ5NEO5PUc,OjJ{N{SzPVk9N2F-
U251 M175OWN6fG:2b4jpZ{BCe3OjeR?= NGrieVkyODBizszN NXXEXIo3OjRiaB?= NF3Edm9FVVOR Mo\FTWM2OD1yLkGwNEDPxE1? NIHIcZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK3OFM6QSd-MkKyO|Q{QTl:L3G+
T98 M3f6WGN6fG:2b4jpZ{BCe3OjeR?= NGrneVAyODBizszN M4C1[lI1KGh? M3PxNGROW09? NF73OnhKSzVyPUCuNVI2KM7:TR?= NYPjd4lHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyO|Q{QTlpPkKyNlc1Ozl7PD;hQi=>
LN18 NH3VVHBEgXSxdH;4bYMhSXO|YYm= M{C5TVExOCEQvF2= M4TlUFI1KGh? NFW2WotFVVOR NF\tbWtKSzVyPUCuNlExKM7:TR?= NUO3TnE6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyO|Q{QTlpPkKyNlc1Ozl7PD;hQi=>
LN443 MmHsR5l1d3SxeHnjJGF{e2G7 Mo\kNVAxKM7:TR?= MkfaNlQhcA>? NEXvToNFVVOR MlTYTWM2OD1yLkKyNEDPxE1? MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ5NEO5PUc,OjJ{N{SzPVk9N2F-
HF66 M1jGSmN6fG:2b4jpZ{BCe3OjeR?= MkPlNVAxKM7:TR?= M1nHNlI1KGh? Mke1SG1UVw>? NEjaW5NKSzVyPUCuNlI2KM7:TR?= NFfh[XE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK3OFM6QSd-MkKyO|Q{QTl:L3G+
HF2303 NXnmcnJ6S3m2b4TvfIlkKEG|c3H5 M{nzVFExOCEQvF2= NF;OVoYzPCCq NV3TU5NSTE2VTx?= NGq5TplKSzVyPUCuNFYxKM7:TR?= NHX4PII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK3OFM6QSd-MkKyO|Q{QTl:L3G+
HF2359 MV\DfZRwfG:6aXOgRZN{[Xl? M3ixOlExOCEQvF2= NG\mSo0zPCCq M3TPV2ROW09? NYqwcYxlUUN3ME2wMlA3OCEQvF2= MmTGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{N{SzPVkoRjJ{Mke0N|k6RC:jPh?=
HF2414 NXvWOJpjS3m2b4TvfIlkKEG|c3H5 NV7UZXJ[OTByIN88US=> NYfDS2xLOjRiaB?= NHr5cW5FVVOR M4j3c2lEPTB;MD6wPFAh|ryP NE[4T409[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK3OFM6QSd-MkKyO|Q{QTl:L3G+
A-673 NXzWe2p[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nHdVExKM7:TR?= M2XyUlk3KGh? NX3QR4NLTE2VTx?= M{nu[GlEPTB;MD6wN|Ih|ryP NEPRSI09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
TC-32 NUHNN2loT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVfT[nJoOTBizszN MmDXPVYhcA>? NHHCUHRFVVOR NUHZfo9RUUN3ME2wMlA{QSEQvF2= Mnn5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
TC-71 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVexNEDPxE1? MmfmPVYhcA>? M3X3RWROW09? M4e5U2lEPTB;MD6xNFIh|ryP MnLTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
SK-N-MC NWjnbnJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml7iNVAh|ryP MnOwPVYhcA>? M4XxXWROW09? MVHJR|UxRTBwMEeyJO69VQ>? NWe3XplvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
CHLA-9 MnrmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVuxNEDPxE1? NX7hTpFSQTZiaB?= M3LkfWROW09? MkPTTWM2OD1yLkCxPEDPxE1? MlX5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
CHLA-10 Ml6yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NET5fGYyOCEQvF2= MYC5OkBp NYe4NIJ{TE2VTx?= NYGwR|Z[UUN3ME2wMlA3OCEQvF2= M3j6[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
CHLA-25 MlzCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnjWNVAh|ryP MV65OkBp M4H1bWROW09? M1HTemlEPTB;MD6xOlgh|ryP NGLmfXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
CHLA-32 MljKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2TqZVExKM7:TR?= M4TOSVk3KGh? NYXreFYzTE2VTx?= NVTWSYgxUUN3ME2wMlE{PiEQvF2= NXXU[3A{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
CHLA-56 NFHp[5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUKxNEDPxE1? MYq5OkBp MXHEUXNQ Moe3TWM2OD1zMDFOwG0> MmrTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
CHLA-258 NF76bFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYWxNEDPxE1? M2\oVFk3KGh? Mnu5SG1UVw>? NVu2O5JNUUN3ME2wMlE{OiEQvF2= M2fxTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
COG-E-352 M4XqTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnfZNVAh|ryP Mn\uPVYhcA>? MlrrSG1UVw>? M13USGlEPTB;MD6wOFMh|ryP MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR2OEW5NUc,OjF2NEi1PVE9N2F-
CHLA-90 NFTkPHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV60XGlyOTBizszN NU\1OoRsQTZiaB?= NEjwWotFVVOR M4HvR2lEPTB;MD6wOlEh|ryP NXu0fVFRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
CHLA-119 MlnnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUXGclhkOTBizszN NYfBWnZtQTZiaB?= NWKwcI5TTE2VTx?= Ml;3TWM2OD1yLkCyNkDPxE1? MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR2OEW5NUc,OjF2NEi1PVE9N2F-
CHLA-122 M3vpbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEP5ZlEyOCEQvF2= MWq5OkBp MYjEUXNQ NFu3bVBKSzVyPUCuNFE6KM7:TR?= NHzJdGE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
CHLA-136 M4fCUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIjqToMyOCEQvF2= NWjIXm9WQTZiaB?= MVnEUXNQ NFHVSVBKSzVyPUCuNFM6KM7:TR?= MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR2OEW5NUc,OjF2NEi1PVE9N2F-
CHLA-140 NF7EXHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIKzdZoyOCEQvF2= MYO5OkBp NHrKZmpFVVOR MorlTWM2OD1yLkCyOkDPxE1? NX;LfnNzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
LA-N-6 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3jjSVExKM7:TR?= MnHnPVYhcA>? MUPEUXNQ M1HKSWlEPTB;MD6wOVQh|ryP Mnj1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
NB-1643 NVnP[GZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4[xWFExKM7:TR?= M13XU|k3KGh? MX3EUXNQ NH32dFRKSzVyPUCuNFM4KM7:TR?= M{O2fFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
NB-EBc1 M{nK[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF:2PGsyOCEQvF2= MmDKPVYhcA>? MmP1SG1UVw>? M4nEe2lEPTB;MD6wOVAh|ryP NVPRUmFmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
SK-N-BE-1 M2DSdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkHENVAh|ryP NILQVWU6PiCq MYHEUXNQ MkHOTWM2OD1yLkCyPEDPxE1? NUTLZ5VyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
SK-N-BE-2 NVTyVFNQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUfUPIhqOTBizszN M3fMPFk3KGh? Ml3VSG1UVw>? NYfqVVJJUUN3ME2wMlA{PiEQvF2= NUCyVVMxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
SMS-KAN NEnXS4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUT5SIZZOTBizszN MYG5OkBp NWfpXG5tTE2VTx?= NHjxRVNKSzVyPUCuNFM1KM7:TR?= NYPJcWlTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
SMS-KANR M4rxS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUOxNEDPxE1? NH3vbG06PiCq MV;EUXNQ NFrZZm9KSzVyPUCuNFI3KM7:TR?= MoHpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
SMS-KCN Mmi4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkHRNVAh|ryP MmftPVYhcA>? M1HVe2ROW09? M{fIemlEPTB;MD6wNVkh|ryP NFe4Voo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
SMS-KCNR NILpNXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmrzNVAh|ryP M{nyV|k3KGh? NFjHWm5FVVOR NGTaS5lKSzVyPUCuNFExKM7:TR?= NUPxenRQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
SMS-LHN NHzFXWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXvQ[5pvOTBizszN NXu1OpFyQTZiaB?= MnTOSG1UVw>? M3G5OmlEPTB;MD6wN|Ih|ryP NEiwb|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
SMS-MSN MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYOxNEDPxE1? M4Cxb|k3KGh? MoXUSG1UVw>? M3X3XGlEPTB;MD6wNlIh|ryP MkTqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
SMS-SAN M2S2eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYnOZ3lvOTBizszN MmP5PVYhcA>? MoLNSG1UVw>? MkPvTWM2OD1yLkCyNEDPxE1? NXrVW21iRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
Granta-4 Ml\kR5l1d3SxeHnjJGF{e2G7 MU[xNEDPxE1? MXO3JIQ> NVPHeWd1UUN3ME2wMlA1OCEQvF2= NUXIS4NpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGyPVE5PjdpPkKxNlkyQDZ5PD;hQi=>
DB Mn;WR5l1d3SxeHnjJGF{e2G7 MU[xNEDPxE1? MoiyO{Bl MYLJR|UxRTBwMESyJO69VQ>? MnmyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF{OUG4OlcoRjJzMkmxPFY4RC:jPh?=
RL MmHqR5l1d3SxeHnjJGF{e2G7 MVSxNEDPxE1? MU[3JIQ> NFjpRmNKSzVyPUCuNFE2KM7:TR?= M2DoNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMkmxPFY4Lz5{MUK5NVg3PzxxYU6=
K562 M4TPcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFf2U|QyOCEQvF2= MYC5OkBp MoXzTWM2OD1yLkC4O{DPxE1? MlXzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjFyOUG2N|MoRjJzMEmxOlM{RC:jPh?=
LAMA-84 NXPs[4JVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmDLNVAh|ryP MVW5OkBp NXHsZmhEUUN3ME2wMlA2PyEQvF2= MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTB7MU[zN{c,OjFyOUG2N|M9N2F-
MM15 M3T6ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoPHOEDPxE1? NHfBT3k4OiCq MYTEUXNQ M4TmTmlEPTB;MD6xN{DPxE1? MlzQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB|OEK4OFQoRjJyM{iyPFQ1RC:jPh?=
OPM1 NYjQVo1wT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1rlPFQh|ryP MlfHO|IhcA>? NWjSVFl7TE2VTx?= MkLtTWM2OD1yLkCzJO69VQ>? M3nVU|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyM{iyPFQ1Lz5{MEO4Nlg1PDxxYU6=
RPM1 MmTTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWC0JO69VQ>? MU[3NkBp NWXScIJyTE2VTx?= Mo\uTWM2OD1zMD6zNkDPxE1? NHjZNZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEO4Nlg1PCd-MkCzPFI5PDR:L3G+
INA6 NWnTfYpwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUG0JO69VQ>? Mn7YO|IhcA>? NV3sRo9pTE2VTx?= M3vsZ2lEPTB;MD6wNFIh|ryP NXXscIZzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCzPFI5PDRpPkKwN|gzQDR2PD;hQi=>
OPM2 MnTPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn3EOEDPxE1? Ml:2O|IhcA>? MoXhSG1UVw>? NXTTOlF3UUN3ME20MlM4KM7:TR?= NYfW[otQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCzPFI5PDRpPkKwN|gzQDR2PD;hQi=>
MM1R MkP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV\abJZFPCEQvF2= M4rYZVczKGh? NHnwenVFVVOR MlvNTWM2OD1zLk[4JO69VQ>? NX:0TZdERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCzPFI5PDRpPkKwN|gzQDR2PD;hQi=>
DOX40 NYnPOZpoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4jselQh|ryP M1vTVlczKGh? NWPNRo01TE2VTx?= NFXTWopKSzVyPUWuOFgh|ryP M{OxSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyM{iyPFQ1Lz5{MEO4Nlg1PDxxYU6=
LR5 M{XqTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVjrclNRPCEQvF2= MnTlO|IhcA>? M33IOmROW09? MmLnTWM2OD1{LkWzJO69VQ>? MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODN6Mki0OEc,OjB|OEK4OFQ9N2F-
U266 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH74RZY1KM7:TR?= NXiwZmgyPzJiaB?= NVu2NGZ6TE2VTx?= M{O3SmlEPTB;MT60N{DPxE1? NGT5Xlc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEO4Nlg1PCd-MkCzPFI5PDR:L3G+
RD M{O3bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXOxNEDPxE1? MnewPVYhcA>? M2\xSGlEPTB;MD6yNlgh|ryP MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODFyOEOzPEc,OjBzMEizN|g9N2F-
Rh41 M2PUcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfDNVAh|ryP M4X0cFk3KGh? NXvzSYJuUUN3ME2wMlA6OCEQvF2= M{P2PFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUC4N|M5Lz5{MEGwPFM{QDxxYU6=
Rh30 MkTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV6xNEDPxE1? NFTyb2M6PiCq NHXkZ|NKSzVyPUCuNlMxKM7:TR?= MnSzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
BT-12 NXr5Oo41T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF;FSowyOCEQvF2= NYfZeo9WQTZiaB?= M4fzO2lEPTB;MD6wOlAh|ryP NXfsNYh{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCxNFg{OzhpPkKwNVA5OzN6PD;hQi=>
CHLA-266 NEPH[4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3vIZ|ExKM7:TR?= M4Lxd|k3KGh? MVfJR|UxRTBwMEeyJO69VQ>? Mlm2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
TC-71 NFnJTZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1LUflExKM7:TR?= NIDzXYY6PiCq M2THVmlEPTB;MD6xNFIh|ryP M3jyeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUC4N|M5Lz5{MEGwPFM{QDxxYU6=
SJ-GBM2 NY\DU2JqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGD4TZkyOCEQvF2= NHzIR3A6PiCq MljDTWM2OD1yLkC1NEDPxE1? MkjZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
NALM-6 NYfGU2pwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1\xOVExKM7:TR?= NYfMXZlLQTZiaB?= M4T3VGlEPTB;MD6wOlIh|ryP MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODFyOEOzPEc,OjBzMEizN|g9N2F-
COG-LL-317 MoTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWCxNEDPxE1? M2fLcVk3KGh? NFy0U29KSzVyPUCuNFQ4KM7:TR?= NF36WoU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEGwPFM{QCd-MkCxNFg{Ozh:L3G+
RS4-11 NF3OXXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXyxNEDPxE1? MkSzPVYhcA>? MVXJR|UxRTBwMEG4JO69VQ>? MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODFyOEOzPEc,OjBzMEizN|g9N2F-
MOLT-4 NUjEZoozT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWixNEDPxE1? MmfqPVYhcA>? NFi3XFdKSzVyPUCuNFI3KM7:TR?= MlzNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
CCRF-CEM MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVTUV3pLOTBizszN NWHOWXd4QTZiaB?= MVLJR|UxRTBwMEm0JO69VQ>? Mn\rQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
Kasumi-1 NWmwNVhuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIXkd4cyOCEQvF2= M{LZZlk3KGh? M1vYcmlEPTB;MD6xNFMh|ryP M1fGSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUC4N|M5Lz5{MEGwPFM{QDxxYU6=
Karpas-299 NETlXpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2fBSlExKM7:TR?= NGjUO486PiCq NU\LVIU5UUN3ME2wMlA{QCEQvF2= NXf2e|lVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCxNFg{OzhpPkKwNVA5OzN6PD;hQi=>
Ramos-RA1 Mke1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NETZUlkyOCEQvF2= M3v3bFk3KGh? NX\NNlh3UUN3ME2wMlEzPyEQvF2= M3P2dVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUC4N|M5Lz5{MEGwPFM{QDxxYU6=
GSS MUnBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M1zrdlczKGi{cx?= MnfoRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCJU2OgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KFeVVEigZZN{[XluIFnDOVAhRSByLkCzPUDPxE1w MnTuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkW2NVcoRjJ3NkK1OlE4RC:jPh?=
LU99A MV;BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MmmzO|IhcHK| MkfXRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCOVUm5RUBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNFYzKM7:TT6= NW\0dJMyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlU3OTdpPkK1OlI2PjF5PD;hQi=>
HL60 NUnqfmVkSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NUfEO4pzPzJiaILz MXLBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiONkCgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KFeVVEigZZN{[XluIFnDOVAhRSByLkC3OEDPxE1w MlS4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkW2NVcoRjJ3NkK1OlE4RC:jPh?=
LC2/ad MmTLRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NX;xNWU2PzJiaILz M1Xpc2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTFOyM4FlKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDXV3Q5KGG|c3H5MEBKSzVyIE2gNE4xPzdizszNMi=> M3jSV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkK1OlE4Lz5{NU[yOVYyPzxxYU6=
MKN45 M1Hqd2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 M{DYU|czKGi{cx?= MnHZRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPS160OUBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNFk{KM7:TT6= MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NU[xO{c,OjV4MkW2NVc9N2F-
HCT116 M4i0W2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 NF\FPI84OiCqcoO= NYq0UZJ[SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JHdUXDhiYYPzZZktKEmFNUCgQUAxNjB7NTFOwG0v NIG4PYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[yOVYyPyd-MkW2NlU3OTd:L3G+
Lu116 M4fwOGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NI\mXFc4OiCqcoO= MkjBRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCOdUGxOkBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNFk4KM7:TT6= NVq0ZZhlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlU3OTdpPkK1OlI2PjF5PD;hQi=>
NCI-H358 NFzQWFVCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NGKzeJg4OiCqcoO= NXv5PG5FSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOR2kuUDN3ODDj[YxteyCjZoTldkA4OiCqcoOgZpkhX1OWODDhd5NigSxiSVO1NEA:KDBwMTFOwG0v NWn1[HFLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlU3OTdpPkK1OlI2PjF5PD;hQi=>
MIAPaCa2 MX3BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NI\hfVg4OiCqcoO= M3X3eWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVnBVIFE[TJiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JHdUXDhiYYPzZZktKEmFNUCgQUAxNjF|IN88UU4> MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NU[xO{c,OjV4MkW2NVc9N2F-
PC14 M{LqRWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NWXwdIZLPzJiaILz M3rSe2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOxOEBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNVch|ryPLh?= NYP5T49vRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlU3OTdpPkK1OlI2PjF5PD;hQi=>
HT-29 M4Lk[2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 M{np[|czKGi{cx?= MlnORY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKVD2yPUBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuN|Mh|ryPLh?= M4HocVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkK1OlE4Lz5{NU[yOVYyPzxxYU6=
HCT15 M2Pyb2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 MVS3NkBpenN? MoL6RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKQ2SxOUBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuO|Qh|ryPLh?= MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NU[xO{c,OjV4MkW2NVc9N2F-
Sf9 M2XEU2Z2dmO2aX;uJIF{e2G7 M4q2fWNwdXCndHn0bZZmKGmwaHnibZRqd25ib3[gdoVkd22kaX7hcpQhdW:3c3WgZZVzd3KjIHvpcoF{\SCDIHX4dJJme3OnZDDpckBqdnOnY4SgV4Y6KGOnbHzzJIlvKHC{ZYPlcoNmKG:oIFHUVEwhU2liPTCwMlAxODNizszNMi=> MnTGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzMEG1OlQoRjJ4MUCxOVY1RC:jPh?=
Sf9 NYDhV4g1TnWwY4Tpc44h[XO|YYm= MWTJcohq[mm2aX;uJI9nKHKnY3;tZolv[W62IH3veZNmKGG3cn;yZUBscW6jc3WgRUBmgHC{ZYPz[YQhcW5iaX7z[YN1KFOoOTDj[YxteyC3c3nu[{BjcW:2aX6tS2xTWkGVTFegZZMhe3Wkc4TyZZRmKGmwIIDy[ZNmdmOnIH;mJHto[W2vYT2zN3BeSVSSLDDJR|UxKD1iMD6wNFEh|ryPLh?= Mn;PQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzMEG1OlQoRjJ4MUCxOVY1RC:jPh?=
HCT116 M{nkS2Z2dmO2aX;uJIF{e2G7 M1jUeGlvcGmkaYTpc44hd2ZiYYXyc5JiKGurbnHz[UBCKGG3dH;wbI9{eGixconsZZRqd25iYYSgWFI5QCCrbjDoeY1idiCKQ2SxNVYh[2WubIOgZpkhcW2vdX7v[ox2d3Knc3PlcoNmKGGwYXz5d4l{NCCLQ{WwJF0hOC5yMEeg{txONg>? NVfZOoc{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[xNFE2PjRpPkK2NVAyPTZ2PD;hQi=>
HCT116 MXrDfZRwfG:6aXPpeJkh[XO|YYm= MnLLR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTGNVOTF4IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yh[2WubDDwdo9tcW[ncnH0bY9vKGK7IFLy[HUhcW6lb4Lwc5JifGmxbjDhd5NigSxiR1m1NEA:KDBwMEOg{txONg>? NV3TVFN7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[xNFE2PjRpPkK2NVAyPTZ2PD;hQi=>
HCT116 MWLGeY5kfGmxbjDhd5NigQ>? M2\3d2lvcGmkaYTpc44hd2ZiYYXyc5JiKGurbnHz[UBDKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHjpd5RwdmViSEOgdIhwe3Cqb4L5cIF1cW:wIHL5JIludXWwb3\seY9z\XOlZX7j[UBidmGueYPpd{whUUN3MDC9JFEvPSEQvF2u MmjhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzMEG1OlQoRjJ4MUCxOVY1RC:jPh?=
BL21 (DE3) Rosetta NXvv[25ITnWwY4Tpc44h[XO|YYm= NEfKOms{OCCvaX7z Moe0TY5pcWKrdHnvckBw\iCKaYOteIFo\2WmIHj1cYFvKEG3cn;yZUBCKGurbnHz[UApOTJ{IITvJFQxKHKnc3nkeYV{MSCneIDy[ZN{\WRiaX6gSZNkcGW{aXPobYEh[2:uaTDCUFIyKCiGRUOpJHJwe2W2dHGgZ4VtdHNidYPpcoch[mmxdHnufYxifGWmIGPUT|Ihe3Wkc4TyZZRmKGmwY4XiZZRm\CCob4KgN|AhdWmwczDifUBJXFKIIHHzd4F6NCCLQ{WwJF0hOC5yMECwOEDPxE1w NVywb4ZCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkezPVEyOzNpPkK3N|kyOTN|PD;hQi=>
HeLa Kyoto MkjSSpVv[3Srb36gZZN{[Xl? NWfxOJZqOjBiaILz NXP2ZpZXUW6qaXLpeIlwdiCxZjDBeZJwemFiQjDrbY5ie2ViaX6gbJVu[W5iSHXMZUBMgW:2bzDj[YxteyCjc4Pld5Nm\CCjczDl[oZm[3Rib36g[Il{fHKrYoX0bY9vKG:oIIDod5Bpdy2qaYP0c45mKEh|IIPldlExKGyndnXsJIlv[3WkYYTl[EBnd3JiMkCgbJJ{NCCLQ{WwJF0hOC5yMEG1JO69VS5? NHT5[mI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{O5NVE{Oyd-MkezPVEyOzN:L3G+
HeLa Kyoto NGXrZZVHfW6ldHnvckBie3OjeR?= NFHsWIczOCCqcoO= NXLOd4pMUW6qaXLpeIlwdiCxZjDBeZJwemFiQTDrbY5ie2ViYYX0c5Bpd3OyaH;yfYxifGmxbjDheEBVcHJ{OEigbY4hcHWvYX6gTIVN[SCNeX;0c{Bk\WyuczDpcoN2[mG2ZXSg[o9zKDJyIHjyd{whUUN3MDC9JFAvODB4NzFOwG0v MorGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd|OUGxN|MoRjJ5M{mxNVM{RC:jPh?=
multiple myeloma M3zEPGZ2dmO2aX;uJIF{e2G7 MVvTeZBxemW|c3nvckBw\iClZXzsJI1qfG:|aYOgbY4hcHWvYX6gcZVtfGmybHWgcZlmdG:vYTDj[YxteyxiSVO1NEA:KDBwMECzJO69VS5? MoPFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh7MUiwPVYoRjJ6OUG4NFk3RC:jPh?=
Calu6 M4H1T2FvfGm2dX3vdkBie3OjeR?= NGXXepQzOCCvZz;r[y=> NEPtT|AzOSCmYYnz MWDBcpRqfHWvb4KgZYN1cX[rdImgZYdicW6|dDDoeY1idiCFYXz1OkBk\WyuczD4[Y5w\3KjZoTl[EBqdiCvb4Xz[UBie3Onc4Pl[EBieyC2dX3vdkBoem:5dHigbY5pcWKrdHnvckBifCB{MDDt[{9s\yxicH:gZollKGGmbXnubZN1\XKnZDDmc5IhOjFiZHH5dy=> MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjFyMUW2OEc,OjZzMEG1OlQ9N2F-
HeLa Kyoto NVLifWVETnWwY4Tpc44h[XO|YYm= M2S2SFAvOjVidV2= NEnPd3IzOCCqcoO= MkjSTY5pcWKrdHnvckBw\iCDdYLvdoEhSSCtaX7hd4UhdG:lYXzpfoF1cW:wIHH0JJNxcW6mbHWgcYlkem:2dXL1cIV{KGmwIHj1cYFvKEinTHGgT5lwfG9iY3XscJMh[XRiMD6yOUB2VSCrbnP1ZoF1\WRiZn;yJFIxKGi{cx?= M1HGSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5M{mxNVM{Lz5{N{O5NVE{OzxxYU6=
MDA-MB-231 NH3YNYdHfW6ldHnvckBie3OjeR?= NWLBc3FqOSC3TR?= M3PPUVQ5KGi{cx?= MUDJcoR2[3Srb36gc4Yh[2i{b33vd49u\SCjbHnnco1mdnRiZHXm[YN1eyCrbjDoeY1idiCPRFGtUWIuOjNzIHPlcIx{KGG2IEGgeW0h[W[2ZYKgOFghcHK|IHL5JGRCWElic4ThbY5qdmdiYnHz[YQhcW2vdX7v[ox2d3Knc3PlcoNmKGG|c3H5 MnnMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl|NUixOFcoRjJ7M{W4NVQ4RC:jPh?=
MDA-MB-231 M2TPR2Z2dmO2aX;uJIF{e2G7 MUSxJJVO M3zNdlQ5KGi{cx?= NV:0S2wxUW6mdXP0bY9vKG:oIHHi[ZJz[W62IIPwbY5ldGViZn;ycYF1cW:wIIfpeIghfHKrcH;sZZIh[W6mIITleJJieG:uYYKgc4NkfXK{ZX7j[UBqdiCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIF1KDFidV2gZYZ1\XJiNEigbJJ{KGK7IFTBVGkhe3SjaX7pcoch[mG|ZXSgbY1ufW6xZnz1c5Jme2OnbnPlJIF{e2G7 MnjQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl|NUixOFcoRjJ7M{W4NVQ4RC:jPh?=
MDA-MB-231 NYXJdlQ{TnWwY4Tpc44h[XO|YYm= NXzCWVlxOC53IIXN MmTKOFghcHK| NVXKUY5XUW6qaXLpeIlwdiCxZjDhcJBp[S22dXL1cIlvKGmwIHj1cYFvKE2GQT3NRk0zOzFiY3XscJMh[XO|ZYPz[YQh[XNiYXLvcIl{cG2nboSgc4YhemWpdXzhdkBtd2OjdHnvckBw\iCycn;0[YlvKGG2IECuOUB2VSCjZoTldkA1QCCqcoOgZpkhTEGSSTDzeIFqdmmwZzDiZZNm\CCrbX31co9ndHWxcnXzZ4Vv[2ViYYPzZZk> MofnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl|NUixOFcoRjJ7M{W4NVQ4RC:jPh?=
MDA-MB-231 M{f3b2Z2dmO2aX;uJIF{e2G7 NHfJ[3kxNjVidV2= M331fFQ5KGi{cx?= NIPOWVlKdmirYnn0bY9vKG:oIFHVVmtCKGmwIHj1cYFvKE2GQT3NRk0zOzFiY3XscJMh[XO|ZYPz[YQh[XNiYXLvcIl{cG2nboSgc4YhemWpdXzhdkBtd2OjdHnvckBw\iCycn;0[YlvKGG2IECuOUB2VSCjZoTldkA1QCCqcoOgZpkhTEGSSTDzeIFqdmmwZzDiZZNm\CCrbX31co9ndHWxcnXzZ4Vv[2ViYYPzZZk> NYK4VXhWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmzOVgyPDdpPkK5N|U5OTR5PD;hQi=>
TC32 NGGxWWtyUFSVIHHzd4F6 NYrrTZZDeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGTDN|Ih[2WubIO= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Saos-2 MYDxTHRUKGG|c3H5 NHjpXZJyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU3Hvd{0zKGOnbHzz NFrGVnE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-SH M4\D[JFJXFNiYYPzZZk> M{PmTZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMXNJKGOnbHzz NI\Ud209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
MG 63 (6-TG R) MmHCdWhVWyCjc4PhfS=> NVnpW5ZCeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF3HJFY{KCh4LWTHJHIqKGOnbHzz M1f1WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
NB1643 MV3xTHRUKGG|c3H5 MVrxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVkJzNkSzJINmdGy| MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
NB-EBc1 M2H1fpFJXFNiYYPzZZk> MXzxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDORk1GSmNzIHPlcIx{ M3L2UVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
MG 63 (6-TG R) NFvyR|RyUFSVIHHzd4F6 NH3MeVByUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBOTyB4MzCoOk1VTyCUKTDj[Yxtew>? MlvQQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
U-2 OS NXe2[FlPeUiWUzDhd5NigQ>? MYDxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDVMVIhV1NiY3XscJM> NIDXS249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SJ-GBM2 NF7JN2ZyUFSVIHHzd4F6 M2rkW5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSj3HRm0zKGOnbHzz NY\4SZl5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
SK-N-MC MkLDdWhVWyCjc4PhfS=> MmLzdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFONLV6tUWMh[2WubIO= MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
NB-EBc1 Mo\kdWhVWyCjc4PhfS=> MnvidWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6ELVXCZ|Eh[2WubIO= M{PNbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
LAN-5 NV7zTW1LeUiWUzDhd5NigQ>? NGnuPGJyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTFHOMVUh[2WubIO= M1nObVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh18 MmW5dWhVWyCjc4PhfS=> MX7xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmhzODDj[Yxtew>? Mm\NQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC MV7xTHRUKGG|c3H5 NWiyeGFweUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhW0tvTj3NR{Bk\Wyucx?= NX:3UJV5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
TC32 M4DKTZFJXFNiYYPzZZk> M{DaNJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHREOzJiY3XscJM> NXnRUWtDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Saos-2 NYTF[Fg4eUiWUzDhd5NigQ>? MX3xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDTZY9{NTJiY3XscJM> M4jONVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-AURKA(T288) / p-EIF4E(S209) / c-Myc; 

PubMed: 28073841     


Inhibition of AURKA with alisertib downregulated p-EIF4E (S209) and c-MYC protein levels as assayed by Western blotting.

phospho-Aurora A / Aurora B; 

PubMed: 22863010     


MLN8237differentially inhibited phosphorylation of Aurora kinases. CMK cells were incubated with 0.1 µM paclitaxel for 18 hr, then DMSO or MLN8237 was added and incubated for 2 hr. The degree of phosphorylation of the Aurora kinases in each sample was determined by Western blot.

H3S10P / H3K27me2 / H3K27me3 / H3K9me2 / H3AcK / H4K16Ac; 

PubMed: 29477140     


THP-1 cells were treated with alisertib or DMSO for 48 h. The levels of histone modifications were detected by western blot analysis with the indicated antibodies. H3 was used as a loading control.

28073841 22863010 29477140
Growth inhibition assay
Cell viability; 

PubMed: 25632225     


PANC-1 and BxPC-3 cells were treated with ALS at concentrations ranging from 0.1 μM to 50 μM for 24 hours. The viability of PANC-1 and BxPC-3 cells determined by MTT assay. ALS, alisertib.

25632225
Immunofluorescence
acetylated α-tubulin / γ-tubulin; 

PubMed: 29401581     


Representative immunofluorescence (IF) image and graph in human PKD1-mutant WT9-7, WT9-12 cells or hTERT-RPE1 (RPE1) cells after 2 hours treatment with vehicle, ganetespib , or alisertib to inhibit AURKA, or combination of alisertib and ganetespib. acetylated α-tubulin (red); γ-tubulin (green); DAPI (blue). Scale bars, 5 μm.

E-cadherin / β-catenin / vimentin / p-SMAD5; 

PubMed: 23334326     


Immunofluorescence analysis of CD24 (-/low) cells treated with1 μM MLN8237 for 48 and 72 h showing reversion of EMT. E-cadherin and p-SMAD5 were labeled in red, β-catenin and vimentin were labeled in green, and DNA was labeled in blue with Hoechst dye.

Centrin-2 / tubulin; 

PubMed: 30899434     


Following inhibition of Aurora A kinase activity with 100 nM alisertib, cells with two or excess centrosomes similarly exhibit disorganized mitotic spindles. Cells with extra centrosomes are efficiently clustered into bipolar spindles prior to anaphase onset while those with supernumerary centrosomes undergo multipolar mitoses. Centrin-2, a marker of centrioles is shown in green, tubulin in red, and chromatin in blue. AurA inhibitor: alisertib.

phospho-Aurora A(T288); 

PubMed: 20382844     


MM1.S cells were treated with DMSO or MLN8237 (0.5μM) for 24 hours and then stained with anti-phospho (Thr288)-Aurora-A kinase antibody (red), αtubulin (green), and DNA (blue). Overlapping localization is shown in the merged images. Arrow indicates Aurora-A autophosphorylation on Thr288 in the centrosome (original magnification ×40). Magnified single mitotic cell image is shown in the right panel. 

29401581 23334326 30899434 20382844
In vivo MLN8237 significantly reduces the tumor burden with tumor growth inhibition (TGI) of 42% and 80% at 15 mg/kg and 30 mg/kg, respectively, and prolongs the survival of mice compared with the control. [2]

Protocol

Kinase Assay:[1]
- Collapse

Aurora A radioactive Flashplate enzyme assay:

Aurora A radioactive Flashplate enzyme assay is conducted to determine the nature and degree of MLN8237-mediated inhibition in vitro. Recombinant Aurora A is expressed in Sf9 cells and purified with GST affinity chromatography. The peptide substrate for Aurora A is conjugated with biotin (Biotin-GLRRASLG). Aurora A kinase (5 nM) is assayed in 50 mM Hepes (pH 7.5), 10 mM MgCl2, 5 mM DTT, 0.05% Tween 20, 2 μM peptide substrate, 3.3 μCi/mL [γ-33P]ATP at 2 μM, and increasing concentrations of MLN8237 by using Image FlashPlates.
Cell Research:[2]
- Collapse
  • Cell lines: MM1.S, MM.1R, LR5, RPMI 8226, DOX40, OPM1, OPM2, INA6, and U266
  • Concentrations: Dissolved in DMSO, final concentrations ~10 μM
  • Incubation Time: 24, 48, and 72 hours
  • Method: Cells are exposed to various concentrations of MLN8237 for 24, 48, and 72 hours. Cells viability is measured using MTT assay, and cell proliferation is measured using 3[H]-thymidine incorporation. For cell cycle analysis, cells are permeabilized by 70% ethanol at -20 °C, and incubated with 50 μg/mL PI and 20 units/mL RNase-A. DNA content is analyzed by flow cytometry using BDFACS-Canto II and FlowJo software. For the detection of apoptosis and senescence, cells are stained with fluorescein isothiocyanate-annexin V and PI. Apoptotic cells are determined by flow cytometric analysis using BDFACS-Canto II and FlowJo software.
    (Only for Reference)
Animal Research:[2]
- Collapse
  • Animal Models: Severe combined immune-deficient (SCID) mice inoculated subcutaneously with MM1.S cells
  • Dosages: ~30 mg/kg/day
  • Administration: Orally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 27 mg/mL (52.03 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5%DMSO+30% PEG300+5%Tween-80+ddH2O
For best results, use promptly after mixing.
6mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 518.92
Formula

C27H20ClFN4O4

CAS No. 1028486-01-2
Storage powder
in solvent
Synonyms N/A
Smiles COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04479306 Recruiting Drug: Alisertib|Drug: Osimertinib|Drug: Sapanisertib Recurrent Lung Non-Small Cell Carcinoma|Stage IIIB Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8 M.D. Anderson Cancer Center June 18 2020 Phase 1
NCT02812056 Withdrawn Drug: Alisertib|Drug: TAK-228 Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs M.D. Anderson Cancer Center|Millennium Pharmaceuticals Inc. September 2016 Phase 1
NCT02719691 Completed Drug: Alisertib|Drug: MLN0128 Metastatic Breast Cancer|Solid Tumors University of Colorado Denver May 13 2016 Phase 1
NCT02367352 Terminated Drug: Alisertib|Drug: Paclitaxel Advanced Solid Tumors|Ovarian Cancer|Small Cell Lung Cancer Millennium Pharmaceuticals Inc.|Takeda March 19 2015 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    What is the suggested formulation of this compound for mouse injection(i.p.)?

  • Answer:

    It can be dissolved in 6% DMSO/50% PEG 300/5% Tween 80/ddH2O at 10 mg/ml as a clear solution.

Aurora Kinase Signaling Pathway Map

Aurora Kinase Inhibitors with Unique Features

Related Aurora Kinase Products

Tags: buy Alisertib (MLN8237) | Alisertib (MLN8237) supplier | purchase Alisertib (MLN8237) | Alisertib (MLN8237) cost | Alisertib (MLN8237) manufacturer | order Alisertib (MLN8237) | Alisertib (MLN8237) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID